IRCT20180211038692N2
Recruiting
Phase 3
Investigating the effect of Citalopram (selective serotonin reuptake inhibitor) on the symptoms of endometriosis patients under medical treatment
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Tehran University of Medical Sciences
- Enrollment
- 80
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Symptomatic patients with endometriosis under medical treatment
- •age between 18 till 45
- •no desire for pregnancy
Exclusion Criteria
- •abnormal findings against endometriosis
- •indication for surgery
- •drug intolerance
- •SSRIs contraindications
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
A comparative study of the effect of citalopram in the prevention of delirium in intubated patients without brain damage in Labafinejad Hospital ICIRCT20190215042716N6Shahid Beheshti University of Medical Sciences62
Completed
Phase 4
the effects of citalopram on brain waves of patients with major depressive disordermajor depressive dosorder.Mood [affective] disordersf30-f39IRCT201203049202N1Research Center For Behavioural Disorders And Substances Abuse Of Hamadan University Of Medical Scie30
Active, not recruiting
Phase 1
A trial to investigate the effect of citalopram for the treatment of typical reflux symptomsEUCTR2017-004174-34-BETargid, KU Leuven100
Completed
Phase 4
The effect of citalopram versus a placebo on central auditory processing in the elderly.ACTRN12614000570684Jose Fernando Polanski60
Active, not recruiting
Phase 2
Evaluating treatment efficacy of citalopram, symbiotic, and mebeverine for children with functional abdominal pain.ACTRN12613000158763Isfahan University of medical silences200